Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.

Ljubicic V, Miura P, Burt M, Boudreault L, Khogali S, Lunde JA, Renaud JM, Jasmin BJ.

Hum Mol Genet. 2011 Sep 1;20(17):3478-93. doi: 10.1093/hmg/ddr265. Epub 2011 Jun 9.

PMID:
21659335
2.

The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets.

Ljubicic V, Burt M, Jasmin BJ.

FASEB J. 2014 Feb;28(2):548-68. doi: 10.1096/fj.13-238071. Epub 2013 Nov 18. Review.

PMID:
24249639
3.

AMP-activated protein kinase at the nexus of therapeutic skeletal muscle plasticity in Duchenne muscular dystrophy.

Ljubicic V, Jasmin BJ.

Trends Mol Med. 2013 Oct;19(10):614-24. doi: 10.1016/j.molmed.2013.07.002. Epub 2013 Jul 25. Review.

PMID:
23891277
4.

Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.

Komen JC, Thorburn DR.

Br J Pharmacol. 2014 Apr;171(8):1818-36. doi: 10.1111/bph.12413. Review.

5.
6.

The Role of AMPK in Neuromuscular Biology and Disease.

Dial AG, Ng SY, Manta A, Ljubicic V.

Trends Endocrinol Metab. 2018 May;29(5):300-312. doi: 10.1016/j.tem.2018.02.010. Epub 2018 Mar 20. Review.

PMID:
29572064

Supplemental Content

Support Center